US-based generic drug maker Mylan and two Indian pharma companies are in the race to acquire Chennai-based Bafna Pharmaceuticals, which makes haemoglobin drug 'Raricap' among other products, said two people privy to the transaction. Founded in 1981, Bafna Pharmaceutical, which makes indictable, generic drugs and haemoglobin drug 'Raricap', is in talk where promoters are intending to divest their stake from the company. "The talks are primarily for a slump sale in nature," said one of the person, who is directly involved into the talk.
Help employers find you! Check out all the jobs and post your resume.
